Omega-carboxyaryl substituted diphenyl ureas as raf kinase...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/78 (2006.01) A61K 31/17 (2006.01) A61K 31/4035 (2006.01) A61K 31/44 (2006.01) C07C 275/20 (2006.01) C07C 275/28 (2006.01)

Patent

CA 2549558

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Cette invention concerne l'utilisation d'un groupe de dérivés arylés de l'urée dans le traitement de maladies faisant intervenir Raf et des compositions pharmaceutiques servant à ce traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Omega-carboxyaryl substituted diphenyl ureas as raf kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Omega-carboxyaryl substituted diphenyl ureas as raf kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omega-carboxyaryl substituted diphenyl ureas as raf kinase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1750137

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.